Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy

por Graff, Julie N., Stein, Mark N., Surana, Rishi, Al Rabadi, Luai, Liu, Eric, Fong, Lawrence, Bailey, Shawna, Latour, Emile, Newby, Timothy A., Moran, Amy E., Beer, Tomasz M.
Publicado 2020

Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance

por Alumkal, Joshi J., Sun, Duanchen, Lu, Eric, Beer, Tomasz M., Thomas, George V., Latour, Emile, Aggarwal, Rahul, Cetnar, Jeremy, Ryan, Charles J., Tabatabaei, Shaadi, Bailey, Shawna, Turina, Claire B., Quigley, David A., Guan, Xiangnan, Foye, Adam, Youngren, Jack F., Urrutia, Joshua, Huang, Jiaoti, Weinstein, Alana S., Friedl, Verena, Rettig, Matthew, Reiter, Robert E., Spratt, Daniel E., Gleave, Martin, Evans, Christopher P., Stuart, Joshua M., Chen, Yiyi, Feng, Felix Y., Small, Eric J., Witte, Owen N., Xia, Zheng
Publicado 2020